思特威(688213.SH):產品已廣泛應用於包括以智能製造、智能篩檢和智能物流讀碼等爲代表的工業製造及物流領域
格隆匯3月11日丨思特威(688213.SH)在投資者互動平臺表示,公司的主營業務爲高性能CMOS圖像傳感器芯片的研發、設計和銷售,產品已被廣泛應用在安防監控、機器視覺、智能手機、汽車電子、工業感知等衆多高科技應用領域,並助力行業向更加智能化和信息化方向發展。 公司的機器視覺產品在全球範圍內擁有顯著的技術影響力和市場地位,產品已廣泛應用於包括以智能製造、智能篩檢和智能物流讀碼等爲代表的工業製造及物流領域,以及無人機、掃地機器人和AR/VR等爲代表的新興應用領域,公司將繼續聚焦於高端核心技術的突破,不斷推出更多高性能的機器視覺應用產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.